Memantine Hydrochloride Torrent (Memantine Hydrochloride)

Memantine binds to the NMDA receptor‑associated ion channel at a site separate from the glutamate binding site, acting as a non‑competitive antagonist. This blocks excessive calcium influx caused by overstimulation, thereby limiting excitotoxic neuronal damage and supporting neuronal function in Alzheimer’s disease.

The specific dose and titration schedule for Memantine Hydrochloride Torrent are determined by the prescribing clinician based on the patient’s condition, renal function, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for memantine in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Memantine belongs to the NMDA receptor antagonist class, differing from acetylcholinesterase inhibitors such as donepezil. While acetylcholinesterase inhibitors increase cholinergic activity, memantine reduces glutamate‑mediated excitotoxicity. Both classes may be used alone or together, depending on disease stage and physician assessment.

Memantine Hydrochloride Torrent should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

The medication is taken orally, usually once daily, with or without food as directed by the prescriber. Tablets should be swallowed whole with a glass of water and not chewed or crushed unless specifically instructed.

Serious risks include seizures, severe skin reactions, hallucinations, cardiac arrhythmias, and rare cases of liver injury. Patients should seek immediate medical attention if they experience any of these symptoms while taking memantine.

Memantine is contraindicated in patients with known hypersensitivity to memantine or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled hypertension, or those taking other NMDA antagonists, and it should be avoided in such cases unless specifically directed by a physician.